Activation of TLR2 and TLR5 did not affect tumor progression of an oral squamous cell carcinoma, YD-10B cells

Journal of Oral Pathology and Medicine

Volumn 39, Issue 10, 2010, Pages 781-785

  Park, Jong Hwan ^a   Yoon, Hyo Eun ^b   Jeon, Do In ^b   Ahn, Sang Gun ^b   Yoon, Jung Hoon ^b  

^a Konyang University   (South Korea)

^b Chosun University   (South Korea)

Author keywords

Invasion; Oral squamous cell carcinoma; Toll like receptors; Tumor progression; VEGF

Indexed keywords

FLAGELLIN; IMIQUIMOD; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; VASCULOTROPIN;

ARTICLE; ASSAY; CELL INVASION; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; COLORIMETRY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; MOUTH CARCINOMA; NONHUMAN; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

BACTERIAL PROTEINS; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; RNA, MESSENGER; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 5; TOLL-LIKE RECEPTORS; TUMOR CELLS, CULTURED;

EID: 77958608580     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2010.00900.x     Document Type: Article

References (22)

1. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
2. Lee MS, Kim YJ. Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem 2007; 76: 447-80.
3. Wolska A, Lech-Maranda E, Robak T. Toll-like receptors and their role in carcinogenesis and anti-tumor treatment. Cell Mol Biol Lett 2009; 14: 248-72.
4. Rakoff-Nahoum S, Medzhitov R. Toll-like receptors and cancer. Nat Rev Cancer 2009; 9: 57-63.
5. Chin D, Boyle GM, Porceddu S, et al. Head and neck cancer: past, present and future. Expert Rev Anticancer Ther 2006; 6: 1111-8.
6. Mao L, Hong WK, Papadimitrakopoulou VA. Focus on head and neck cancer. Cancer Cell 2004; 5: 311-6.
7. Kundu SD, Lee C, Billips BK, et al. The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells. Prostate 2008; 68: 223-9.
8. Pei Z, Lin D, Song X, et al. TLR4 signaling promotes the expression of VEGF and TGFbeta1 in human prostate epithelial PC3 cells induced by lipopolysaccharide. Cell Immunol 2008; 254: 20-7.
9. Xie W, Wang Y, Huang Y, et al. Toll-like receptor 2 mediates invasion via activating NF-kappaB in MDA-MB-231 breast cancer cells. Biochem Biophys Res Commun 2009; 379: 1027-32.
10. Shaykhiev R, Behr J, Bals R. Microbial patterns signaling via Toll-like receptors 2 and 5 contribute to epithelial repair, growth and survival. PLoS ONE 2008; 3: e1393.
11. Lin TH, Kuo HC, Chou FP, et al. Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide. BMC Cancer 2008; 8: 58.
12. Hayashi Y, Fukumi A, Matsukado K, et al. Estimation of photon dose generated by a short pulse high power laser. Radiat Prot Dosimetry 2006; 121: 99-107.
13. Pikarsky E, Porat RM, Stein I, et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004; 431: 461-6.
14. Sugawara Y, Uehara A, Fujimoto Y, et al. Toll-like receptors, NOD1, and NOD2 in oral epithelial cells. J Dent Res 2006; 85: 524-9.
15. Miyake K. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin Immunol 2007; 19: 3-10.
16. Smith MF Jr, Mitchell A, Li G, et al. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J Biol Chem 2003; 278: 32552-60.
17. Hirao K, Yumoto H, Takahashi K, et al. Roles of TLR2, TLR4, NOD2, and NOD1 in pulp fibroblasts. J Dent Res 2009; 88: 762-7.
18. Huang B, Zhao J, Shen S, et al. Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling. Cancer Res 2007; 67: 4346-52.
19. Matijevic T, Marjanovic M, Pavelic J. Functionally active toll-like receptor 3 on human primary and metastatic cancer cells. Scand J Immunol 2009; 70: 18-24.
20. Kim WY, Lee JW, Choi JJ, et al. Increased expression of Toll-like receptor 5 during progression of cervical neoplasia. Int J Gynecol Cancer 2008; 18: 300-5.
21. Lee JW, Choi JJ, Seo ES, et al. Increased toll-like receptor 9 expression in cervical neoplasia. Mol Carcinog 2007; 46: 941-7.
22. Lee EJ, Kim J, Lee SA, et al. Characterization of newly established oral cancer cell lines derived from six squamous cell carcinoma and two mucoepidermoid carcinoma cells. Exp Mol Med 2005; 37: 379-90.